# Filing Detail

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-18-011631
Filing Date
2018-08-23
Accepted
2018-08-23 16:10:23
Documents
42

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT NO. 1 TO FORM F-1 | ff12018a1_tizianalife.htm | F-1/A | 3211840
2 | FORM OF UNDERWRITING AGREEMENT | ff12018a1ex1-1_tiziana.htm | EX-1.1 | 325573
3 | MEMORANDUM AND ARTICLES OF ASSOCIATION OF TIZIANA LIFE SCIENCES PLC | ff12018a1ex3-1_tiziana.htm | EX-3.1 | 575629
4 | FORM OF DEPOSIT AGREEMENT | ff12018a1ex4-1_tiziana.htm | EX-4.1 | 255748
5 | FORM OF REPRESENTATIVE'S WARRANT | ff12018a1ex4-3_tiziana.htm | EX-4.3 | 107100
6 | OPINION OF COOLEY (UK) LLP | ff12018a1ex5-1_tiziana.htm | EX-5.1 | 52028
7 | LICENSE AGREEMENT RELATING TO MILCICLIB BETWEEN NERVIANO MEDICAL SERVICES S.R.L. | ff12018a1ex10-1_tiziana.htm | EX-10.1 | 567436
8 | LICENSE AND SUBLICENSE AGREEMENT RELATING TO CD3 (NI-0401) BETWEEN NOVIMMUNE SA | ff12018a1ex10-2_tiziana.htm | EX-10.2 | 119086
9 | LICENSE AND SUBLICENSE AGREEMENT RELATING TO IL-6R (NI-1201) BETWEEN NOVIMMUNE S | ff12018a1ex10-3_tiziana.htm | EX-10.3 | 106754
10 | LICENSE AGREEMENT RELATING TO A NOVEL FORMULATION OF FORALUMAB IN A MEDICAL DEVI | ff12018a1ex10-4_tiziana.htm | EX-10.4 | 180434
11 | ANNUAL LEASE FOR 55 PARK LANE, SUITE 14A, LONDON W1K 1NA, UNITED KINGDOM, DATED | ff12018a1ex10-5_tiziana.htm | EX-10.5 | 413548
12 | FIVE-YEAR LEASE FOR 420 LEXINGTON AVENUE, SUITE 2525, NEW YORK, UNITED STATES, D | ff12018a1ex10-6_tiziana.htm | EX-10.6 | 408694
13 | ANNUAL LEASE FOR 3085 OLD EASTON ROAD, DOYLESTOWN, PENNSYLVANIA, UNITED STATES, | ff12018a1ex10-7_tiziana.htm | EX-10.7 | 31104
14 | TIZIANA LIFE SCIENCES PLC EMPLOYEE SHARE OPTION PLAN, WITH NON-EMPLOYEE SUB-PLAN | ff12018a1ex10-8_tiziana.htm | EX-10.8 | 415802
15 | CONTRACT OF EMPLOYMENT, DATED MAY 2017, BETWEEN THE REGISTRANT AND DR. KUNWAR SH | ff12018a1ex10-9_tiziana.htm | EX-10.9 | 391025
16 | FORM OF DEED OF INDEMNITY FOR BOARD MEMBERS | ff12018a1ex10-10_tiziana.htm | EX-10.10 | 43134
17 | LIST OF SUBSIDIARIES | ff12018a1ex21-1_tiziana.htm | EX-21.1 | 4551
18 | CONSENT OF MAZARS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, REGARDING | ff12018a1ex23-1_tiziana.htm | EX-23.1 | 4205
19 | GRAPHIC | ex3-1_001.jpg | GRAPHIC | 6355
20 | GRAPHIC | ex3-1_002.jpg | GRAPHIC | 2559
21 | GRAPHIC | ex4-1_001.jpg | GRAPHIC | 205623
22 | GRAPHIC | ex4-1_002.jpg | GRAPHIC | 5770
23 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 7229
24 | GRAPHIC | ex10-2_001.jpg | GRAPHIC | 353296
25 | GRAPHIC | ex10-2_002.jpg | GRAPHIC | 383035
26 | GRAPHIC | ex10-2_003.jpg | GRAPHIC | 451042
27 | GRAPHIC | ex10-2_004.jpg | GRAPHIC | 106617
28 | GRAPHIC | ex10-3_001.jpg | GRAPHIC | 608641
29 | GRAPHIC | ex10-3_002.jpg | GRAPHIC | 371225
30 | GRAPHIC | ex10-5_003.jpg | GRAPHIC | 25377
31 | GRAPHIC | ex10-6_001.jpg | GRAPHIC | 207936
32 | GRAPHIC | ex10-7_001.jpg | GRAPHIC | 40978
33 | GRAPHIC | ex10-8_001.jpg | GRAPHIC | 2514
34 | GRAPHIC | ex10-9_001.jpg | GRAPHIC | 2559
35 | GRAPHIC | image_001.jpg | GRAPHIC | 5487
36 | GRAPHIC | image_004.jpg | GRAPHIC | 17305
37 | GRAPHIC | image_005.jpg | GRAPHIC | 14606
38 | GRAPHIC | image_007.jpg | GRAPHIC | 15154
39 | GRAPHIC | img_1n.jpg | GRAPHIC | 100418
40 | GRAPHIC | img_3n.jpg | GRAPHIC | 237926
41 | GRAPHIC | img_7n.jpg | GRAPHIC | 103790
42 | GRAPHIC | img_8n.jpg | GRAPHIC | 32185
| Complete submission text file | 0001213900-18-011631.txt |  | 11773443

Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-226368 | Film No.: 181034874
SIC: 2834 Pharmaceutical Preparations